Zacks.com on MSN2h
Regeneron Gets Positive CHMP Opinion for Multiple Myeloma Drug
Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...
Cure Today6h
FDA Accepts Ordspono Resubmission in R/R Follicular Lymphoma Treatment
The FDA has accepted the resubmission of the BLA of Ordspono for review in relapsed/refractory follicular lymphoma following previous systemic therapy.
pharmaphorum22h
5 takeaways from Super Bowl LIX: What health and pharma can learn from it
Super Bowl advertising has always been about pushing boundaries, capturing attention, and setting new creative standards. But this year, the risk-taking was noticeably dialled down. While 2024 ...